Personalized cAnceR TreatmeNt and caRe (PARTNR) platform
Many women with breast cancer continue to struggle with fatigue years after diagnosis and treatment. Although treatments to alleviate these symptoms do exist, their effectiveness varies from person to person. In 2020, the PARTNR project for personalised cancer treatment and care was launched; by combining medical data with data on day-to-day living it aims to provide a deeper understanding of fatigue to come to optimal treatment recommendations.
PARTNR is already yielding promising results. To continue the project (PARTNR proof-of-concept), KWF Dutch Cancer Society has awarded follow-up funding to explore the route towards implementation for the personalized treatment advice.
PARTNR is a collaboration between the University of Twente, ZiekenhuisGroep Twente (ZGT), Helen Dowling Institute (HDI), Roessingh rehabilitation centre, Roessingh Research and Development (RRD), Netherlands Comprehensive Cancer Organisation (IKNL), Evidencio, and the University Medical Centre of Groningen (UMCG).
The PARTNR project was supported by KWF Kankerbestrijding and NWO Domain AES, as part of their joint strategic research programme: Technology for Oncology II. The collaboration project is co-funded by the PPP Allowence made available by Health~Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships.
PARTNR proof-of-concept is supported by KWF Kankerbestrijding.